Description of Business and Summary of Significant Accounting Policies (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Description of Business and Summary of Significant Accounting Policies [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Cash, Cash Equivalents and Restricted Cash |
The following is a summary of cash, cash equivalents and restricted cash at September 30, 2025 and December 31, 2024:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Diluted Net Loss Per Share | For the three and nine months ended
September 30, 2025 and 2024, the Company’s potentially dilutive shares, which include outstanding common stock options, restricted
stock units, vested unissued shares of common stock and warrants, have not been included in the computation of diluted net loss per share
as the result would have been anti-dilutive.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||